Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?
- 31 March 2004
- journal article
- review article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 58 (3), 976-983
- https://doi.org/10.1016/j.ijrobp.2003.09.097
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckJournal of Clinical Oncology, 2003
- Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human CarcinomasThe American Journal of Pathology, 2002
- Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 Upregulates p27KIP1 and p15INK4B and Induces G1 Arrest in Oral Squamous Carcinoma Cell LinesOncology, 2002
- ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression.International Journal of Cancer, 2001
- The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathwayOncogene, 2001
- EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cellsCancer Letters, 2001
- Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell linesInternational Journal of Cancer, 2001
- Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferationBritish Journal of Surgery, 2001
- Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitorInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.JCI Insight, 1995